Three hundred Black and Latinx teens in Chicago will be recruited to participate in the first clinical trial to measure the potential health benefits of
Just days after closing its Seagen acquisition, Pfizer has struck a deal to expand its antibody-drug conjugate portfolio even further. Nona Biosciences, the partnership-driven antibody
A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable